Terms: = Endocrine gland cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Treatment
943 results:
1. Prevalence and Incidence of Fractures in Patients With Nonfunctional Adrenal Tumors.
Lindh JD; Patrova J; Mannheimer B; Falhammar H
JAMA Netw Open; 2024 Apr; 7(4):e246453. PubMed ID: 38619841
[TBL] [Abstract] [Full Text] [Related]
2. Accessibility to ERCP-performing hospitals among patients with pancreatic cancer living in SEER regions.
Tavakkoli A; Beauchamp A; Prasad T; Zhu H; Singal AG; Elmunzer BJ; Kubiliun NM; Kwon RS; Hughes AE; Pruitt SL
Cancer Med; 2024 Feb; 13(3):e7020. PubMed ID: 38400670
[TBL] [Abstract] [Full Text] [Related]
3. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
4. Comparative outcomes and prognostic indicators in adrenalectomy for adrenal metastasis.
Kwak J; Bae HL; Jung Y; Choi J; Hwang H; Kim JH; Kim SJ; Lee KE
Surg Endosc; 2024 Apr; 38(4):1884-1893. PubMed ID: 38316662
[TBL] [Abstract] [Full Text] [Related]
5. Agricultural exposure and risk of ovarian cancer in the AGRIculture and cancer (AGRICAN) cohort.
Renier M; Hippert J; Louis-Bastien W; Tual S; Meryet-Figuiere M; Vigneron N; Marcotullio E; Baldi I; Lebailly P;
Occup Environ Med; 2024 Feb; 81(2):75-83. PubMed ID: 38199811
[TBL] [Abstract] [Full Text] [Related]
6. treatment results of Para-Testicular Rhabdomyosarcoma (PT-RMS) using radiation as an alternative to retro-peritoneal nodal dissection: A single Institution experience.
Abdelazim YA; Zaki MF; Abdel Mohsen MM; Emad RM; Mohamad HG; Abdelfatah D; Kalil EM
Arch Ital Urol Androl; 2023 Nov; 95(4):11642. PubMed ID: 38193230
[TBL] [Abstract] [Full Text] [Related]
7. Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular cancer.
Wiesen B; Atwell M; Leavitt C; Clark N; Kessler E; Lam E; Flaig T; Kukreja J; Kim S; Maroni P; Cost NG
JCO Oncol Pract; 2024 Mar; 20(3):361-369. PubMed ID: 38127812
[TBL] [Abstract] [Full Text] [Related]
8. Significance of Ultra-Radical Surgery in Extensive Metastatic Ovarian Growing Teratoma Syndrome.
Li S; Wang T; Du H; Tang H; Zhang T; Zhang R; Zhang X; Yang J
Oncology; 2023; 101(12):773-781. PubMed ID: 38096801
[TBL] [Abstract] [Full Text] [Related]
9. Radioactive iodine therapy for follicular thyroid cancer: a 15 years follow-up study of Chinese patients.
Shi H; Yang B; Feng JI; Li JH; Cheng X; Li YJ; Fu Y; Xu XD; Qian LH; Tang LJ; Liu W
Nucl Med Commun; 2024 Mar; 45(3):169-174. PubMed ID: 38095140
[TBL] [Abstract] [Full Text] [Related]
10. Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study.
Debets P; Dreijerink KMA; Engelsman A; Dahele M; Haak HR; Steenaard RV; Kapiteijn E; Corssmit E; Menke-van der Houven van Oordt CW
Eur J Cancer; 2024 Jan; 196():113424. PubMed ID: 37977106
[TBL] [Abstract] [Full Text] [Related]
11. High serum levels of inflammatory markers are associated with early recurrence in patients with high-grade serous ovarian cancer after platinum therapy.
Brzezinska B; Mysona DP; Richardson KP; Rungruang B; Hopkins D; Bearden G; Higgins R; Johnson M; Satter KB; McIndoe R; Ghamande S; Purohit S
Gynecol Oncol; 2023 Dec; 179():1-8. PubMed ID: 37862814
[TBL] [Abstract] [Full Text] [Related]
12. Long-term control of acromegaly after pituitary surgery in South-Eastern Norway.
Falch CM; Dupont AK; Olarescu NC; Wiedmann M; Dahlberg D; Bollerslev J; Berg-Johnsen J; Heck A
Acta Neurochir (Wien); 2023 Oct; 165(10):3003-3010. PubMed ID: 37665404
[TBL] [Abstract] [Full Text] [Related]
13. Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial.
Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Singh N; Manchanda R; Kalsi JK; Woolas R; Arora R; Casey L; Dawnay A; Sharma A; Williamson K; Apostolidou S; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Jacobs IJ; Parmar MKB
Lancet Oncol; 2023 Sep; 24(9):1018-1028. PubMed ID: 37657461
[TBL] [Abstract] [Full Text] [Related]
14. The impact of lymph node ratio on disease recurrence in papillary thyroid microcarcinoma.
de Jong MC; Mahipal M; Ngiam KY; Tan WB; Yang SP; Parameswaran R
Ann R Coll Surg Engl; 2023 Sep; 105(7):632-638. PubMed ID: 37652084
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of postoperative outcomes of minimally invasive distal pancreatectomy for left-sided pancreatic tumors based on the modified frailty index: a retrospective cohort study.
Park Y; Hwang DW; Lee JH; Song KB; Jun E; Lee W; Kwak BJ; Kim SC
Int J Surg; 2023 Nov; 109(11):3497-3505. PubMed ID: 37598358
[TBL] [Abstract] [Full Text] [Related]
16. Clinical features and prognostic factors of spinal metastatic pancreatic cancer: A retrospective observational study.
Yun JH; Cho PG; Kim KT; Shin DA; Kim KN; Kim SH; Noh SH
Medicine (Baltimore); 2023 Jul; 102(28):e34264. PubMed ID: 37443474
[TBL] [Abstract] [Full Text] [Related]
17. Lateral neck dissection for the treatment of synchronous and metachronous lateral neck metastasis of N1b papillary thyroid cancer.
Yun HJ; Lee JS; Lee JS; Kim SM; Chang H; Lee YS; Chang HS; Park CS
Front Endocrinol (Lausanne); 2023; 14():1166640. PubMed ID: 37424860
[TBL] [Abstract] [Full Text] [Related]
18. Intraoperative paraaortic lymph node sampling during resection for pancreatic cancer: evolving role in the modern chemotherapy era.
Kazami Y; Oba A; Ono Y; Sato T; Inoue Y; Saiura A; Takahashi Y; Ito H
HPB (Oxford); 2023 Oct; 25(10):1169-1178. PubMed ID: 37357111
[TBL] [Abstract] [Full Text] [Related]
19. Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine treatment Status.
Yamamoto M; Miyauchi A; Ito Y; Fujishima M; Sasaki T; Kudo T
Thyroid; 2023 Oct; 33(10):1182-1189. PubMed ID: 37310904
[No Abstract] [Full Text] [Related]
20. Bilaterality, not multifocality, is an independent risk factor for recurrence in low-risk papillary thyroid cancer.
Rodriguez Schaap PM; Lin JF; Metman MJH; Dreijerink KMA; Links TP; Bonjer HJ; Nieveen van Dijkum EJM; Dickhoff C; Kruijff S; Engelsman AF
J Natl Cancer Inst; 2023 Sep; 115(9):1071-1076. PubMed ID: 37267155
[TBL] [Abstract] [Full Text] [Related]
[Next]
